The information below is intended only to provide the recommendations and rationale from the Committee to Evaluate Drugs (CED) and the Executive Officer decisions regarding the listing of products on the Formulary, funding of cancer drugs through the New Drug Funding Program, funding through the Exceptional Access Program, or funding through the Special Drugs Program.

For further details on what types of information is provided, please refer to the Transparency of the Drug Review Process.

Do not rely upon any of the information provided on this site for medical diagnosis or treatment. Please consult your primary health care provider about any personal health concerns. This website does not provide any medical diagnosis, symptom assessment, health counseling or medical opinion for individual users. The information contained on this site is intended for information purposes only and does not constitute medical advice for patients. For more detailed information on prescription drugs, please consult a qualified healthcare professional.

List chronologically      Archives

BRAND NAME	GENERIC NAME	DATE PUBLISHED
Abraxane	nab-paclitaxel	April 2010
Aclasta – osteoporosis	zoledronic acid	January 2009
Actonel 75mg and 150mg	risedronate sodium	July 2010
Actonel Plus Calcium	risedronate sodium/calcium carbonate	July 2007
Adcirca	tadalafil	May 2011
Adderall XR	mixed amphetamine salts	October 2009
Advagraf	tacrolimus (extended-release)	April 2010
Afinitor	everolimus	May 2011
Aldara	imiquimod	February 2010
Alimta – non-small cell lung cancer	pemetrexed	August 2008
Alimta - MPM	pemetrexed	July 2007
Altace 15mg capsule	ramipril 15mg capsule	January 2008
Altace HCT	ramipril/hydrochlorothiazide	June 2008
Altace Plus Felodipine	ramipril/felodipine	October 2007
Alvesco	ciclesonide	May 2008
Aricept RDT	donepezil rapidly dissolving tablet	June 2008
Aromasin – early breast cancer	exemestane	August 2008
Atacand	candesarten cilexetil	February 2010
Avalide	irbesartan/hydrochlorothiazide	October 2007
Avastin – GBM	bevacizumab	October 2011
Avastin - for metastatic colorectal cancer	bevacizumab	September 2009
Azilect	rasagiline	August 2010
Biphentin	methylphenidate extended release	February 2010
Caelyx – recurrent ovarian cancer	pegylated liposomal doxorubicin	October 2007
Cipralex	escitalopram	November 2008
Celsentri	maraviroc	October 2009
Combigan 10mL – new package size	brimonidine/timolol	November 2008
Cubicin	daptomycin	November 2009
Combination treatment for Pulmonary Arterial Hypertension (PAH)		July 2010
Cymbalta for DPN	duloxetine for DPN	August 2010
DDAVP Melt	desmopressin	May 2008
Denavir	penciclovir	June 2008
Diovan	valsartan	July 2007
Diovan-HCT	valsartan/ hydrochlorothiazide	October 2009
Dovobet	calcipotriol/betamethasone	October 2008
Duragesic 12	fentanyl 12.5mcg/hr transdermal patch	October 2007
Elaprase	idursulfase	May 2008
Eloxatin – adjuvant treatment of colorectal cancer	oxaliplatin	October 2008
Eloxatin – metastatic colorectal cancer	oxaliplatin	October 2008
Enablex	darifenacin	July 2007
Eprex - additional dosage forms	epoetin alfa - additional dosage forms	November 2009
Erbitux – head & neck cancer	cetuximab	April 2011
Erbitux – metastatic colorectal cancer	cetuximab	April 2011
Exelon Patch	rivastigmine patch	October 2009
Exjade	deferasirox	March 2010
Faslodex	fulvestrant	April 2010
Femara	letrozole	January 2008
Fluanxol Depot	flupenthixol decanoate	February 2010
Fludara – CLL	fludarabine tablet	October 2011
Fosavance 70/140	alendronate-cholecalciferol	July 2010
Fosavance	alendronate/cholecalciferol	July 2007
Gemzar – metastatic breast cancer	gemcitabine hydrochloride	August 2008
Gleevec – ALL	imatinib	January 2011
Gleevec - CML	imatinib mesylate	July 2007
Gleevec - GIST	imatinib mesylate	July 2007
Humalog Mix50	insulin lispro/insulin lispro protamine	August 2010
Humira – psoriatic arthritis	adalimumab	October 2007
Hycamtin – small cell lung cancer	topotecan	August 2008
Hycamtin – recurrent ovarian cancer	topotecan	October 2007
Hypurin	insulin porcine	May 2008
Intelence	etravirine	March 2009
Invega	paliperidone	November 2009
Januvia	sitagliptin	March 2012
Kaletra pediatric tablet	lopinavir / ritonavir	March 2010
Lantus SoloStar	insulin glargine	August 2010
Lantus	insulin glargine	March 2009
Leukotriene Receptor Antagonists (Singulair, Accolate)	leukotriene receptor antagonists (montelukast, zafirlukast)	November 2010
Levemir Penfill	insulin detemir	August 2010
Linessa	desogestrel/ethinyl estradiol	January 2008
Long-Acting medications for Attention Deficit Hyperactivity Disorder (ADHD)	long-acting medications for attention deficit hyperactivity disorder (ADHD)	January 2011
Lucentis	ranibizumab	June 2008
MabCampath	alemtuzumab	August 2008
Metvix	methyl aminolevulinate	October 2011
Mezavant	mesalamine (5-ASA)	June 2010
Myozyme	alglucosidase alfa	December 2009
Nexavar – hepatocellular carcinoma	sorafenib	January 2009
Nexavar – metastatic renal cell carcinoma	sorafenib	October 2008
Nuvaring	etonogestrel / ethinyl estradiol	February 2010
One-Alpha	alfacalcidol	November 2009
Omnaris	ciclesonide	November 2009
Orencia	abatacept	May 2011
OxyContin	oxycodone hydrochloride	July 2007
Posanol	posaconazole	April 2009
Prolastin	alpha1-proteinase inhibitor	April 2011
Prezista	darunavir	January 2008
Ralivia	tramadol hydrochloride ER	June 2010
Rasilez	aliskiren	October 2009
Rebif initiation package	interferon beta1a	February 2010
Resultz	isopropyl myristate	April 2010
Revatio	sildenafil	July 2010
Revlimid – myelodysplastic syndrome	lenalidomide	April 2009
Rituxan – CLL	rituximab	October 2011
Rituxan – rheumatoid arthritis	rituximab	January 2009
Seasonale	levonorgestrel / ethinyl estradiol	April 2009
Seroquel XR	quetiapine fumarate	June 2010
Sensipar	cinacalcet	December 2008
Simponi – ankylosing spondylitis	golimumab	April 2011
Simponi – psoriatic arthritis	golimumab	April 2011
Simponi – rheumatoid arthritis	golimumab	April 2011
Sprycel – ALL	dasatinib	January 2011
Sprycel – chronic myeloid leukemia	dasatinib	December 2008
Stalevo	levodopa/ carbidopa/ entacapone	October 2009
Sutent – MRCC	sunitinib	May 2008
Sutent – GIST	sunitinib	October 2007
Taxol – recurrent ovarian cancer	paclitaxel	October 2007
Thelin	sitaxsentan	January 2011
Torisel	temsirolimus	May 2011
Tridural	tramadol hydrochloride ER	June 2010
Trosec	trospium chloride	August 2008
Truvada	emtricitabine/Tenofovir disoproxil fumarate	June 2008
Tysabri	natilizumab	February 2011
Vantas	histrelin acetate	February 2010
Vectibix	panitumumab	February 2009
Vfend	voriconazole	October 2007
Vidaza	azacitidine	May 2011
Volibris	ambrisentan	July 2010
Xeloda – gastric cancer	capecitabine	August 2008
Xeloda	capecitabine (as component of CAPOX regimen)	October 2009
Xarelto	rivaroxaban	June 2010
Yasmin	drospirenone/ethinyl estradiol	January 2008
Zytram XL	tramadol hydrochloride XL	June 2010
To view PDF format files, you need to have Adobe Acrobat® Reader installed on your computer.    You can download this free software from the Adobe website.